Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
23 hedge funds and large institutions have $28.2M invested in Zosano Pharma Corporation in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.
61% more capital invested
Capital invested by funds: $17.5M → $28.2M (+$10.7M)
8% less funds holding
Funds holding: 25 → 23 (-2)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Nexthera Capital
New York
|
+$1.4M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$124K |
| 3 |
Morgan Stanley
New York
|
+$118K |
| 4 |
VF
Virtu Financial
New York
|
+$95.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$55.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.05M |
| 2 |
TI
Telemetry Investments
New York
|
-$307K |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$289K |
| 4 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$284K |
| 5 |
FIA
FNY Investment Advisers
New York
|
-$197K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PCP
26
Proficio Capital Partners
Newton,
Massachusetts
| – | -$82K | -571 | Closed |
|
27
Goldman Sachs
New York
| – | -$58K | -409 | Closed |
|
28
Millennium Management
New York
| – | -$48K | -337 | Closed |
|
ZSAN Hedge Fund Activity: Q3 2018 in Review
23 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q3 2018, worth a combined $28.2M — up 61% from $17.5M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ZSAN and 4 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was Nexthera Capital, adding an estimated $1.4M. The largest seller was Sabby Management, cutting an estimated $1.05M.
- 23 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q3 2018, down from 25 in Q2 2018.
- Funds reported $28.2M of Zosano Pharma Corporation stock for Q3 2018, up 61% quarter-over-quarter.
- 4 funds opened new Zosano Pharma Corporation positions in Q3 2018 and 6 closed out, a net change of -2 holders.
- The largest Zosano Pharma Corporation buyer in Q3 2018 was Nexthera Capital, an estimated $1.4M added.
- The largest Zosano Pharma Corporation seller in Q3 2018 was Sabby Management, an estimated $1.05M sold.
Based on aggregated 13F filings for Q3 2018.